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Abstract
Hypersensitivity to the fruit mango is extremely rare and can exhibit either as immediate or delayed reactions. Since 1939, only 22 
patients (10 with immediate type I reactions and 12 with delayed) have been documented with allergy to mango. History of atopy 
and geographical region may influence the type of reaction. Immediate reactions occured most often in patients with history of atopy, 
while delayed reactions developed in non-atopic individuals. Clustering of delayed hypersensitivity reports from Australia and imme-
diate reactions from Europe has been documented. We report a 50-year-old man with immediate type I hypersensitivity to mango, 
who developed cough, wheezing dyspnoea, generalised itching and abdominal discomfort after ingestion of mango. Life threatening 
event can also happen making it imperative to diagnose on time, so as to prevent significant morbidity and potential mortality.
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Streszczenie
Nadwrażliwość na owoce mango jest bardzo rzadkim zjawiskiem i może przebiegać zarówno jako reakcja natychmiastowa, jak 
i opóźniona. Od 1939 roku udokumentowano alergię na mango tylko u 22 pacjentów (u 10 z reakcjami typu natychmiastowego 
i  u 12 z reakcją opóźnioną). Wydaje się, że wywiad atopowy oraz region geograficzny mogą wpływać na rodzaj reakcji. Na-
tychmiastowe reakcje obserwowano najczęściej u pacjentów z wywiadem atopii, natomiast reakcje opóźnione byłych częstsze 
u pacjentów bez takiego wywiadu. Dane epidemiologiczne wskazują, że na terenie Australii dominuje nadwrażliwość z opóźnionym 
typem reakcji, w Europie zaś przeważają reakcje typu natychmiastowego. 
W pracy przedstawiono przypadek 50-letniego mężczyzny z nadwrażliwością typu I natychmiastowego na alergeny owocu mango, 
u którego po spożyciu mango wystąpił kaszel, świszczący oddech i duszność, uogólniony świąd skóry i dolegliwości brzuszne. 
Diagnostyka w takich sytuacjach powinna być przeprowadzona możliwie szybko, aby wdrożyć wtórną profilaktykę, uniknąć 
ekspozycji i zapobiegać stanom zagrażającym życiu w przebiegu nadwrażliwości.
Słowa kluczowe: allergy, anaphylaxis, bronchial asthma, contact dermatitis, mango, urticaria 
Pneumonol. Alergol. Pol. 2014; 82: 445–453
Introduction 
The fruit mango (Mangifera indica), often 
known as the ‘king of fruits’, belongs to the family 
Anacardiacae. During the summer months, India 
produces nearly half of the mangoes cultivated 
throughout the world and is the national fruit 
of the country. Despite being consumed in large 
quantities and in many forms in our country, hy-
persensitivity reactions to mango are extremely 
rare. Hypersensitivity to the fruit mango can ma-
nifest in two forms, immediate and delayed. To 
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date, there are only 22 patients with documented 
hypersensitivity to mango. Of these 22 patients, 
10 [1–9] exhibited immediate hypersensitivity 
while 12 [10–17] had delayed hypersensitivity 
reactions. Of the 10 patients with immediate 
hypersensitivity, two were reported from India 
[6, 9]. The mango allergen is known to cross 
react with Artemisia pollen, birch pollen, poison 
ivy, carrot, celery, pistachio nut, banana, tomato 
and papaya [8]. Paucity of the literature on the 
subject prompted this report of the 50-year-old 
man with immediate hypersensitivity reaction 
in the form of wheezing dyspnoea, generalised 
itching and abdominal discomfort after ingestion 
of fresh mango.
Case report
A 50-year-old male office worker, a never-
smoker, was referred to our Institute for evalu-
ation of hypersensitivity to the fruit mango. He 
had wheezing dyspnoea and cough for 10 years 
which initially were episodic but had recently 
become troublesome. These complaints were 
preceded by nasal symptoms which had commen-
ced about 15 years ago in the form of paroxysmal 
sneezing, rhinorrhoea and nasal itching. Nasal 
blockage and post nasal drip too occurred off and 
on. All respiratory symptoms aggravated during 
change of season and whenever he ingested man-
go during the mango season. This also caused 
skin allergy which manifested as itching and 
rashes. Symptomatic treatment and avoidance of 
mangoes for past 10 years had partially controlled 
his symptoms. 
Physical examination revealed a middle aged 
man in no acute distress.There was no pallor, icte-
rus, clubbing, cyanosis or pedal oedema. Oxygen 
saturation at room air was 98%. Diaphragmatic 
excursion was equal on both sides. On ausculta-
tion, vesicular breath sounds along with bilateral 
polyphonic expiratory rhonchi were audible over 
all lung fields. Nasal mucosa was erythematous.
Complete blood counts revealed a total leu-
cocyte count of 9900 cells per cubic millimeter 
with an eosinophil count of 10.8%. Absolute eosi-
nophil count was 1000 cells per cubic millimeter. 
Serum total Ig E value was 358 kUA/L (reference 
range < 64.00). Specific IgE against mango was 
1.38 kUA/L (Immunocap [100] system) suggesting 
presence of moderate levels of mango specific an-
tibodies. Renal as well as hepatic functions were 
within normal limits. The chest radiograph reve-
aled no abnormalities but a non-contrast CT scan 
of the paranasal sinuses showed bilateral maxil-
lary, bilateral ethmoidal and left sphenoidal 
sinusitis. Pulmonary function testing showed 
a ratio of FEV1/FVC of 62% with a FVC of 3.99 L 
(126% of predicted), an FEV1 of 2.48 L (95% of 
predicted) but there was no significant increase 
in FEV1 after inhalation of 400 micrograms of 
salbutamol. This was suggestive of an obs-
tructive pattern with mild airflow limitation. 
Neither was there any significant reversibility 
nor did the peak flow diary reveal any circadian 
variation.
Skin prick testing with the battery of stan-
dard aeroallergens demonstrated immediate hy-
persensitivity to weeds (Ageratum, Amaranthus 
spinosus, Argemone, Artemisia, Gynandropsis 
and Parthenium). Prick to prick testing from 
a fresh ripe mango was done along with a negative 
control (buffered normal saline [1 × 1 mm]) and 
a positive control (histamine [6 × 6 mm]). This 
elicited an immediate type I hypersensitivity re-
action to the mango extract (14 × 10 mm). 
A week later, the patient agreed to ingest 
a small slice of fresh mango under observation in 
the emergency room. After an informed consent 
was taken, he was examined prior to ingestion of 
mango and spirometry and peak flow rates were 
also recorded. Oxygen saturation at room air was 
98%. Within 5 minutes of ingestion of mango, 
he complained of itching in the oral cavity. Ge-
neralised itching and abdominal discomfort too 
commenced which peaked after 1 hour. This was 
followed by a bout of coughing, audible wheezing 
dyspnoea and throat irritation. Polyphonic rhon-
chi were audible over all lung fields. The peak 
flow rate fell from 4.10 L/min to 2.92 L/min, 
a decrease of 1180 mL (28%). The spO2 fell to 93% 
at room air and FEV1 fell from 3.3 L to 2.67 L. 
These manifestations subsided within half an 
hour after injectable adrenaline, pheniramine 
and dexamethasone along with nebulisation with 
salbutamol, ipratropium and budesonide. After 
2 hours of mango ingestion, he vomited mango 
remnants (Table 1).
A diagnosis of bronchial asthma and allergic 
rhinitis along with immediate hypersensitivity 
to the fruit mango was made and the patient was 
strongly advised not to ingest mango in any form. 
He was also initiated on a combination of inhaled 
budesonide and formoterol along with mometa-
sone nasal spray. This was done as soon as the 
diagnosis was established. With this, the patient 
experienced significant relief and his symptoms 
were minimised on maintenance therapy. 
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Table 1. Mango ingestion provocation test
Time Clinical profile spO2 PFR (L/min) FEV1 (L)
Pre-mango ingestion No symptoms with normal vesicular breathing 98% 410 3.3
5 minutes Itching in oral cavity 98% 420 –
15 minutes Generalised itching and abdominal discomfort 98% 410 –
30 minutes Increasing generalised itching and abdominal discomfort 98% 410 –
45 minutes Further aggravation of generalised itching and abdominal discomfort 97% 400 –
60 minutes Generalised itching and abdominal discomfort accompanied by throat 
irritation, bout of coughing, audible wheezing dyspnoea and polyphonic 
rhonchi
95% 290 –
70 minutes Aggravation of all symptoms including generalised itching and abdominal 
discomfort, throat irritation, coughing, wheezing dyspnoea, polyphonic 
rhonchi
93% 200 2.67
Post-treatment 15 
minutes
↓ itching, ↓cough and wheezing dyspnoea, ↓ rhonchi 96% 320 –
Post-treatment 30 
minutes
↓cough and wheezing dyspnoea, ↓ rhonchi 96% 360 –
Post-treatment 60 
minutes
Vomiting containing mango remnants, no cough, wheezing dyspnoea or 
rhonchi
98% 400 –
Discussion
Mango is native to southern Asia and has 
been cultivated in the Indian subcontinent for 
thousands of years. It is consumed in various 
forms both during the season as well as off se-
ason. During season, it is partaken in form of 
fresh fruits, shakes and ice creams while during 
off season, it is cherished as pickles, jams and 
juices. Immediate hypersensitivity can manifest 
as anaphylaxis, angioedema, erythema, urticaria, 
wheezing dyspnoea while delayed reaction as 
contact dermatitis, oral allergy syndrome and 
periorbital oedema [18].
A recent review [18] presented 22 patients 
with documented hypersensitivity to the fruit 
mango, 10 of whom had immediate hypersen-
sitivity, while 12 presented with delayed hy-
persensitivity reactions with predominant skin 
manifestations. The first report of an allergic 
reaction to mango was a description of delay-
ed hypersensitivity manifestation from USA 
in 1939 by Zakon [10]. The report described 
a young female who developed acute vesicular 
dermatitis involving lips and circumoral area, 
24 hours after ingestion of mango. The first case 
of immediate hypersensitivity too was reported 
from USA by Kahn [1] in 1942. The patient deve-
loped hoarseness, dyspnoea and wheezing within 
30 minutes of mango ingestion. These symptoms 
were relieved with injectable epinephrine. Our 
patient too, a case of immediate hypersensitivity 
type I reaction to mango, experienced bout of 
coughing, wheezing dyspnoea, throat irritation 
within 1 hour of mango ingestion.
Of the ten patients documented with imme-
diate reaction to mango, erythema developed in 
three [3–4, 7], angioedema in five [2, 4, 6–8], respi-
ratory distress/dyspnea in nine [1–9] and anaphy-
laxis in two patients [2, 3], one of whom had 
a life threatening anaphylactic shock [2]. Symp-
toms in most of these patients occurred almost 
immediately [3–9], while in two patients, symp-
toms commenced in around 30 minutes [1, 2]. 
History of atopy, also present in our patient, was 
available in eight others [1, 2, 4, 5, 7–9].
Skin prick tests and immunoassays of serum 
food specific IgE levels can detect the allergen 
specific IgE. These tests are only supportive and 
can aid in the diagnosis but it is imperative that 
it be performed in light of an appropriate clinical 
history. In IgE mediated food allergy, the wheal 
size correlates with the likelihood of clinical al-
lergy. However, wheal size can be highly variable 
as it depends on age, diurnal variation and site 
on the body where SPT is performed. The indi-
vidual’s skin reactivity as well as the SPT device 
and reagents used also play a role [19]. 
The ICON statement on “Food Allergy” [19] 
issued jointly by the American Academy of Aller-
gy, Asthma and Immunology; European Academy 
of Allergy and Clinical Immunology; World Al-
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lergy Organization; and the American College of 
Allergy, Asthma & Immunology has stressed the 
need for studies to define the diagnostic accuracy 
of 95% positive predictive value wheal sizes for 
different foods, ages, diseases, and populations. 
Information regarding the skin allergy test to 
mango was available in eight of the ten patients 
with immediate hypersensitivity to mango and 
was positive in all [2, 4, 5, 6–9]. Our patient too 
had a skin prick test positive to mango extract. 
Food specific IgE is also often used for esta-
blishing the diagnosis of food allergy but has the 
same status as skin prick testing [19]. Specific IgE 
against mango was evaluated in six patients [4–8], 
but was positive in only three [5, 6, 8]. In our 
patient too, specific IgE against mango antigens 
was detected in moderate levels. The possible 
explanation behind the under detection of specific 
IgE may be the unstability of the corresponding 
allergens, which remain undetected and also the 
current IgE detection system appears to lack some 
of the specific mango allergens [18]. Combining 
skin prick testing results with serum food specific 
IgE may be of value in diagnosing food allergy [20]. 
Wheal size with skin prick testing and serum food 
specific IgE levels correspond with the plausibility 
of clinical allergy but it must be highlighted that 
they do not correlate with or predict the severity 
of allergic reaction to a food [19].
Although, the double-blind, placebo-con-
trolled food challenge (DBPCFC) remains the 
gold standard for the diagnosis of food allergy, it 
is less frequently performed as it requires time, 
huge resources and appropriate set-up. In clinical 
practice, single blind or open food challenges 
are generally performed, though DBPCFC is the 
most specific test to confirm food allergy. There is 
a risk of immediate allergy and anaphylaxis, so it 
is essential that food challenge should always be 
performed in a well equipped facility under medi-
cal supervision with appropriate medications and 
resources available for emergency management of 
anaphylaxis [19].
Immediate hypersensitivity is a classical IgE 
mediated reaction and usually occurs in individu-
als who are previously sensitised to mango anti-
gens [5]. Sensitisation may occur by prior mango 
ingestion or by intake of other fruits belonging 
to Anacardiaceae family. Even unrecognisable 
forms such as fruit punch can also sensitise the 
patient [2]. Allergenicity of mango nectar persists 
even after heating, enzymatic degradation and 
mechanically caused tissue degradation as evi-
denced by allergic reaction to canned or packaged 
mango [21].
Mango antigen also cross-reacts with arte-
misia pollen, birch pollen, poison ivy, mugwort, 
celery, carrot, pistachio nut, tomato, papaya and 
banana [10]. Mostly, Bet v1, Bet v6, and Art v1 
related allergens lead to cross-reactions between 
mango and other plants and fruits [7]. A study has 
documented that the common epitopes are sha-
red by allergens from mango fruit and allergens 
from birch pollen, mugwort pollen, celery, and 
carrot [22]. Mango allergy was also seen in indi-
viduals with latex hypersensitivity [7, 23]. The 
possible explanation is that multiple antigens can 
bind to an IgE antibody at corresponding sites, 
thus mediating an immune response. Allergens, 
termed as profilins, responsible for cross reac-
tivities between botanically unrelated pollens 
and fruits can account for this phenomenon [22]. 
However, this has yet to be proved conclusively.
The first case of delayed hypersensitivity to 
mango was reported in 1939 in USA. Subsequent 
reports are from Asia, Australia and North Ameri-
ca. Amongst the twelve such patients documented 
in the literature so far [10–17], urticaria was pre-
sent in eight [10–13, 15], oral allergy syndrome in 
two [1, 17] and periorbital edema in two [13, 15]. 
Three of these patients [10, 13, 15] developed the 
symptoms after mango ingestion, while in the 
remaining nine patients, the reaction occurred 
after contact with mango skin or bark of mango 
tree [11, 12, 14, 16, 17]. Duration of onset of symp-
toms was variable and ranged from 4 hours [11] 
to 7 days [12]. Patch testing, done in ten patients 
[11, 13–17], was positive in all. Cross reactivity 
was not reported in any patient nor was there any 
information regarding specific IgE antibody aga-
inst mango antigen in any of the twelve patients.
Delayed hypersensitivity reaction to mango 
is cell mediated and was seen mainly in form of 
contact dermatitis, oral allergy syndrome and 
periorbital oedema. Direct contact with the mango 
or tree itself and ingestion too, can lead to a cell 
mediated reaction. Sensitising substances present 
in the skin, bark, pericarp as well as the mango 
pulp up to five millimeters below the skin include 
uroshiol, cardol, limonene and B-pinene [18].   
Since 8 of the 10 patients with immediate 
type I hypersensitivity reactions had a history of 
atopy, it appears that atopy may be a risk factor 
for a type I reaction with mango. In contrast, in 
patients with delayed manifestations, history of 
atopy was seen in only one of 12 documented 
patients, suggesting that delayed hypersensitivity 
occurs in non-atopic subjects.
Further, geographical region may influence 
the type of reaction. There are five reports of 
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hypersensitivity to mango from Australia, all of 
whom presented with delayed hypersensitivity 
reaction and none had history of atopy. All these 
five patients had negative skin prick test for man-
go while patch testing was positive in all [11, 16] 
(Table 2). On the other hand, all five patients 
documented from Europe had immediate type I 
hypersensitivity reactions and history of atopy 
was present in all. All these five patients also had 
a positive skin prick test for mango [4, 5, 7, 8] 
(Table 3). Of the six patients documented from 
Asia, two were immediate from India while four 
presented with delayed hypersensitivity (two 
from Japan, one from Thailand and one from Ko-
rea) [14, 15, 17]. There are no reports of delayed 
hypersensitivity reaction from India (Table 4). Of 
the six patients documented from North America, 
all from USA, three each presented with immedia-
te and delayed hypersensitivity (Table 5).
Both in vitro and the in vivo tests were perfor-
med in our patient to confirm the mango allergy. 
Skin test with extract showed wheal and flare 
reaction of more than histamine (positive control) 
indicating IgE against mango allergen bound to 
the mast cells were degranulated by the allergen 
extract. Similarly, Immuncocap results indicated 
the free IgE in serum of patient. In the study, 
skin prick testing was done with weeds to find 
out whether food-specific IgE antibodies were 
cross-reacting in nature or not. Therefore, an oral 
mango challenge was performed to confirm food 
allergy. These data proved that our patient had 
immediate hypersensitivity to mango.
Our report highlights the fact that hyper-
sensitivity manifestations to mango can include 
both immediate and delayed reactions. Immediate 
reaction can also result in life threatening events. 
If not diagnosed on time, allergic reactions to 
the fruit can lead to significant morbidity and 
possible mortality. 
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